Rehmani 2013.
Methods |
Allocation: randomized Controlled: active comparator Blinding: double‐blind Arm: 2‐arm, parallel‐group design Centre: single centre Study duration: not reported |
|
Participants |
Inclusion criteria: participants presenting to emergency department with acute painful crisis of SCD Exclusion criteria: not reported Baseline characteristics N: 106 participants; 106 VOC episodes Gender: not reported in abstract Age: not reported Number randomized: 54 intervention; 52 control Number completed: not reported Setting and location: King Abdulaziz Hospital, Al Ahsa, Saudi Arabia |
|
Interventions |
Treatment group (54 participants; 54 VOC episodes):
Control group (52 participants; 52 VOC episodes):
Duration of treatment: duration of painful crisis Follow‐up period: not reported Cointerventions/additional analgesia: rescue analgesics |
|
Outcomes |
Primary outcomes
Secondary outcomes
|
|
Notes | Sources of funding: not reported | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk |
Quote: "106 patients were randomised to treatment, morphine or paracetamol." Comment: no clear method of randomization. |
Allocation concealment (selection bias) | Unclear risk | Comment: insufficient information. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Comment: insufficient information. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Comment: insufficient information. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Comment: insufficient information. |
Selective reporting (reporting bias) | High risk | Comment: not all outcomes listed in methods were reported in the results, e.g. VRS; however, unclear due to abstract only. |
Size | Unclear risk | Comment: total participants 106, 50–199 participants per treatment arm. |
Other bias | Low risk | Comment: no other possible sources of bias. |